Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16786
Title: Rhenium and technetium-oxo complexes with thioamide derivatives of pyridylhydrazine bifunctional chelators conjugated to the tumour targeting peptides octreotate and cyclic-RGDfK
Authors: North, Andrea J
Karas, John A
Ma, Michelle T
Blower, Philip J
Ackermann, Uwe
White, Jonathan M
Donnelly, Paul S
Date of Publication: 2-Aug-2017
Citation: Inorganic Chemistry 2017; online first: 2 August
Abstract: This research aimed to develop new tumor targeted theranostic agents taking advantage of the similarities in coordination chemistry between technetium and rhenium. A γ-emitting radioactive isotope of technetium is commonly used in diagnostic imaging, and there are two β- emitting radioactive isotopes of rhenium that have the potential to be of use in radiotherapy. Variants of the 6-hydrazinonicotinamide (HYNIC) bifunctional ligands have been prepared by appending thioamide functional groups to 6-hydrazinonicotinamide to form pyridylthiosemicarbazide ligands (SHYNIC). The new bidentate ligands were conjugated to the tumor targeting peptides Tyr3-octreotate and cyclic-RGD. The new ligands and conjugates were used to prepare well-defined {M═O}3+ complexes (where M = 99mTc or natRe or 188Re) that feature two targeting peptides attached to the single metal ion. These new SHYNIC ligands are capable of forming well-defined rhenium and technetium complexes and offer the possibility of using the 99mTc imaging and 188/186Re therapeutic matched pairs.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16786
DOI: 10.1021/acs.inorgchem.7b01247
ORCID: 0000-0002-0707-6257
0000-0002-3349-7346
0000-0001-5373-0080
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/28766938
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.